Skip to content
Life Sciences Series A Founded 2021

Zafrens

Provider of single-cell multi-omics analysis platform for researchers. The company specializes in building tools and generating insights at the interface of biology, chemistry, and engineering. It offers multi-omic assays and the study of mechanistic insights into the RNA regulatory layer. Founded in 2021, headquartered in San Diego, United States. The company has raised $31.0M in funding at the series a stage. The…

📍 San Diego, United States · Genomics,

Funding snapshot

Last roundSeries A
Amount$31M
Date4 February 2025
Total raised$31M
Team size30

About

Provider of single-cell multi-omics analysis platform for researchers. The company specializes in building tools and generating insights at the interface of biology, chemistry, and engineering. It offers multi-omic assays and the study of mechanistic insights into the RNA regulatory layer. Founded in 2021, headquartered in San Diego, United States. The company has raised $31.0M in funding at the series a stage. The team comprises 30 (Jun 30, 2026) employees. The company operates in the Genomics sector with additional focus on Life Sciences Platforms and Tools. Its business model centers on Single Cell Genomics. Founded in 2021, headquartered in San Diego, United States. The company has raised $31.0M at the Series A stage. Backed by investors including Prime Movers Lab, BlueYard, KOFA Healthcare Investments, Global Brain, FoundersX Ventures and others.

Business model

Genomics > Enabling Technologies > Instrument Systems > Single Cell Genomics,

Life Sciences Platforms and Tools > Instruments > Cell Biology > Cell Analysis > Single Cell Multi Omics

Institutional investors

Prime Movers Lab BlueYard KOFA Healthcare Investments Global Brain FoundersX Ventures Alix Ventures Possible Ventures Iaso Ventures Hawktail imec.xpand

Latest coverage

No articles yet.

Raising like Zafrens?

Analyze your pitch deck before your next raise.

Analyze My Deck →